Dr. Noah Berkowitz talks about a new test available commercially that determines risk level of cardiovascular complications for diabetic patients. He also discusses a new drug that his company Alteon, Inc. is developing to treat these complications.
New Drug for Cardiovascular Complications-Diabetes
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Dr. Noah Berkowitz talks about a new test available commercially that determines risk level of cardiovascular complications for diabetic patients. He also discusses a new drug that his company Alteon, Inc. is developing to treat these complications.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Beyond Plaques: Current Concepts in Alzheimer’s Pathophysiology
IgG4-RD Case Conversations: The Peculiarities of Kidney Involvement
IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement
New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
Level Up Your Skills: Tailoring Management of HF
Personalizing Care Within the RCC Treatment Paradigm
Collaborative Insights to Solve the Puzzle of Bladder Cancer
Understanding hypertrophic cardiomyopathy and recent guidelines
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?